Quoin Pharmaceuticals Q1 EPS $(1.77) Misses $(1.72) Estimate

Benzinga Newsdesk www.benzinga.com Negative 78.1%

Neg 78.1% Neu 0% Pos 0%

Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.72) by 2.91 percent. This is a 72.77 percent increase over losses of $(6.50) per share from the same period last year.